#1
|
||||
|
||||
giant prolactinoma
Effectiveness of long-term cabergoline treatment for giant prolactinoma: study of 12 men
CLINICAL STUDY European Journal of Endocrinology, Vol 156, Issue 2, 225-231 Objective: To review our experience with cabergoline, a D2-selective dopamine agonist, for the treatment of giant prolactinomas. [Ссылки доступны только зарегистрированным пользователям ] |